文献速递皮肤肿瘤

医疗机构特征对梅克尔细胞癌结局的影响:回顾性队列研究

The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort study.
PubMed 文献 · J Am Acad Dermatol · 2019-08-29

该研究基于美国国家癌症数据库2004-2014年成人梅克尔细胞癌病例进行回顾性队列分析,发现机构学术隶属(P<.001)和病例量(P<.001)均与患者生存显著相关。学术机构治疗患者5年生存率为63.0%(SE 1.7),倾向评分匹配的非学术机构患者为53.4%(SE 1.9);高病例量机构为67.4%(SE 2.1),匹配的低/中病例量机构为58.6%(SE 2.0)。

要点

  • 学术机构与高病例量中心治疗与梅克尔细胞癌患者生存改善显著相关。
  • 学术机构患者5年生存率63.0%,匹配非学术机构为53.4%。
  • 高病例量机构患者5年生存率67.4%,匹配低/中病例量机构为58.6%。

核心结论

  • 在学术中心和高病例量中心治疗梅克尔细胞癌与患者生存显著改善相关。

研究设计与样本

  • 回顾性队列分析,纳入美国国家癌症数据库2004-2014年诊断的成人梅克尔细胞癌病例。

主要发现

  • 机构学术隶属(P < .001)和病例量(P < .001)均与患者生存显著相关。
  • 学术机构治疗患者5年生存率为63.0%(标准误[SE] 1.7),倾向评分匹配的非学术机构患者为53.4%(SE 1.9)。
  • 高病例量机构治疗患者5年生存率为67.4%(SE 2.1),倾向评分匹配的低和中等病例量机构患者为58.6%(SE 2.0)。

临床怎么用

  • 梅克尔细胞癌患者可考虑转诊至学术中心或高病例量中心以改善生存结局。

局限性

  • 缺乏疾病特异性生存和局部复发数据。
  • 需进一步研究评估合并症和疾病特异性生存,以确定经验丰富中心是否改善梅克尔细胞癌治疗结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous work has suggested that facility-level characteristics, such as case volume and academic affiliation, are associated with patient survival for rare malignancies. Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer with high mortality and rising incidence. The effect of facility characteristics on MCC outcomes is not yet established. OBJECTIVE: We aimed to investigate whether facility academic affiliation or case volume was associated with MCC patient survival. METHODS: We conducted a retrospective cohort analysis of US adult MCC cases diagnosed during 2004-2014 in the National Cancer Database. RESULTS: Both facility academic affiliation (P < .001) and case volume (P < .001) were significantly associated with patient survival. The 5-year survival of patients treated at academic facilities was 63.0% (standard error [SE] 1.7) and that of a propensity score- matched cohort of patients treated at nonacademic facilities was 53.4% (SE 1.9). The 5-year survival of patients treated at high-case volume facilities was 67.4% (SE 2.1) and that of a propensity score-matched cohort of patients treated at low- and intermediate-case volume facilities was 58.6% (SE 2.0). LIMITATIONS: Disease-specific survival and local recurrence data were not available. CONCLUSION: Treatment of MCC at academic and high-volume centers is associated with significantly improved patient survival. Further studies evaluating comorbidities and disease-specific survival are needed to establish whether experienced centers have improved outcomes in MCC treatment.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Cheraghlou S, Agogo GO, Girardi M, et al. The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort study. J Am Acad Dermatol. 2019. PMID: 31473294. doi:10.1016/j.jaad.2019.08.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。